Welcome to LookChem.com Sign In|Join Free
  • or

76547-98-3

Post Buying Request

76547-98-3 Suppliers

Recommended suppliersmore

Product FOB Price Min.Order Supply Ability Supplier
Lisinopril
Cas No: 76547-98-3
No Data 1 Metric Ton 20 Metric Ton/Day SHINING HEALTH GROUP LIMITED Contact Supplier
High quality Lisinopril supplier in China
Cas No: 76547-98-3
No Data No Data No Data Simagchem Corporation Contact Supplier
Lisinopril
Cas No: 76547-98-3
USD $ 1.0-1.0 / Kilogram 1 Kilogram 1000 Kilogram/Month Enke Pharma-tech Co.,Ltd. (Cangzhou, China ) Contact Supplier
Lisinopril Manufacturer/High quality/In stock
Cas No: 76547-98-3
USD $ 3.0-3.0 / Kilogram 1 Kilogram 1-100 Metric Ton/Month Hangzhou Dayangchem Co., Ltd. Contact Supplier
buy Lisinopril from China supplier factory manufacturer
Cas No: 76547-98-3
USD $ 10.0-10.0 / Kilogram 1 Kilogram 800 Metric Ton/Month Crovell Biotech (Hebei) Co., Ltd. Contact Supplier
Lisinopril
Cas No: 76547-98-3
No Data 100 Gram 100 Kilogram/Month HENAN SUNLAKE ENTERPRISE CORPORATION Contact Supplier
C21H31N3O5 Lisinopril 76547-98-3
Cas No: 76547-98-3
No Data 1 Metric Ton 100 Metric Ton/Day Henan Tianfu Chemical Co., Ltd. Contact Supplier
Lisinopril CAS NO.76547-98-3
Cas No: 76547-98-3
No Data 10 Gram Metric Ton/Day Jilin Tely Imp.& Exp.Co., Ltd. Contact Supplier
Lisinopril 76547-98-3
Cas No: 76547-98-3
USD $ 100.0-150.0 / Kilogram 1 Kilogram 1000 Metric Ton/Day Wuhan Monad Medicine Tech Co.,LTD Contact Supplier
GMP factory supply 99% raw powder lisinopril
Cas No: 76547-98-3
USD $ 1.0-1.0 / Kilogram 1 Kilogram 100000 Kilogram/Month Wuhan Recedar Biotechnology Co., Ltd Contact Supplier

76547-98-3 Usage

Uses

Labeled Lisinopril, intended for use as an internal standard for the quantification fo Lisinopril by GC- or LC-mass spectrometry.

Brand name

Prinivil (Merck); Zestril (AstraZeneca).
InChI:InChI:1S/C21H31N3O5/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29)

76547-98-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name lisinopril

1.2 Other means of identification

Product number -
Other names Cipral

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:76547-98-3 SDS

76547-98-3Related news

The incidence of all-cause, cardiovascular and respiratory disease admission among 20,252 users of Lisinopril (cas 76547-98-3) vs. perindopril: A cohort study07/19/2019

BackgroundMajor international guidelines do not offer explicit recommendations on any specific angiotensin-converting enzyme inhibitor (ACEI) agent over another within the same drug group. This study compared the effectiveness of lisinopril vs. perindopril in reducing the incidence of hospital a...detailed

Fast and sensitive LC–MS/MS method for the simultaneous determination of Lisinopril (cas 76547-98-3) and hydrochlorothiazide in human plasma07/18/2019

A sensitive and rapid liquid chromatography-tandem mass spectrometry (LC–MS/MS) method has been developed for the simultaneous determination of lisinopril (LIS) and hydrochlorothiazide (HCTZ) in human plasma using their labeled internal standards (ISs). Sample pre-treatment involved solid phase...detailed

Daily Lisinopril (cas 76547-98-3) vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial07/16/2019

PurposeChemoradiation (CRT) is an integral treatment modality for patients with locally advanced lung cancer. It has been hypothesized that current use of an angiotensin-converting enzyme inhibitor during CRT may be protective for treatment-related lung damage and pneumonitis.detailed

The cough reflex is upregulated by Lisinopril (cas 76547-98-3) microinjected into the caudal nucleus tractus solitarii of the rabbit07/15/2019

We have previously shown that cough potentiation induced by intravenous administration of the AT1 receptor antagonist losartan is lower than that induced by the ACE inhibitor lisinopril in anesthetized and awake rabbits. Since losartan and lisinopril cross the blood–brain barrier, their central...detailed

An innovative validated spectrofluorimetric method for determination of Lisinopril (cas 76547-98-3) in presence of hydrochlorothiazide; application to content uniformity testing07/14/2019

A new sensitive and discriminating spectrofluorimetric method has been developed and validated for determination of Lisinopril, one of the angiotensin converting enzyme inhibitors, in its pure bulk form and pharmaceutical tablets. The reaction of Lisinopril with ethylacetoacetate and formaldehyd...detailed

Effect of amlodipine, Lisinopril (cas 76547-98-3) and allopurinol on acetaminophen-induced hepatotoxicity in rats07/13/2019

BackgroundExposure to chemotherapeutic agents such as acetaminophen may lead to serious liver injury. Calcium deregulation, angiotensin II production and xanthine oxidase activity are suggested to play mechanistic roles in such injury.detailed

Lisinopril (cas 76547-98-3) inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis07/12/2019

Therapeutic interventions are still limited in the treatment of liver fibrosis even though an incredible number of publications related to silymarin are produced. This is due to the complex molecular pathogenesis. Several studies pointed to the role of renin-angiotensin system (RAS) in hepatic f...detailed

Randomized Trial of Lisinopril (cas 76547-98-3) Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer07/11/2019

BackgroundTrastuzumab is highly effective for human epidermal growth factor receptor type 2 (HER2)–positive breast cancer but is associated with a decline in left ventricular ejection fraction.detailed

Please post your buying leads,so that our qualified suppliers will soon contact you!

*Required Fields